Base editing shows promise for treating sickle cell disease and beta thalassemia

FHS
July 3, 2023
4:12 pm

Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease (SCD) and beta thalassemia.

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce

January 15, 2024

Study identifies 9 novel genes linked to gestational diabetes

The largest genetic study of gestational diabetes to date has led to a discovery of nine novel genetic regions linked to this severe and common

January 5, 2024

GARDP and Orchid Pharma enter antibiotic sublicense deal

The antibiotic received approvals from the US Food and Drug Administration and the European Medicines Agency in 2019 and 2020, respectively. Credit: fizkes / Shutterstock.com.

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.